Bronchiectasis. Bronchiectasis with (acute) exacerbation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with definite diagnosis of aggravated non-fibrocystic bronchiectasis disease; Not having moderate to severe heart failure (EF>50); Stable vital signs; Having a controlled and stable drug regimen (according to the opinion of a pulmonologist) during the study; Informed consent to participate in research.
Exclusion criteria
Exclusion criteria: Gastrointestinal problems such as severe nausea and vomiting; The presence of various cancers of the respiratory system; The presence of chronic kidney and liver disease at the same time; History of any surgery on the respiratory system at least in the last year; A history of receiving any antibiotics in the last month; A history of receiving any corticosteroid drugs in the past month; Pregnancy and breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measuring oxygen saturation (o2sat). Timepoint: Once every two weeks. Method of measurement: Standard method with pulse oximetry device.;Measurement of lung volumes and capacities. Timepoint: Once every two weeks. Method of measurement: Standard method with spirometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measuring discomfort from breathing (Dyspnea). Timepoint: Once every two weeks. Method of measurement: Using standard Borg questionnaire.;Measurement of white blood cells. Timepoint: Once every two weeks. Method of measurement: By standard laboratory method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahroud University of Medical Sciences